Answers are grounded in this paper and cite their sources.
Although it is well known that valproic acid (VPA) can induce hyperammonemia [1], few reports have been concerned with its relationship to hypothyroidism. Here we present a bipolar disorder patient with hypothyroidism (in fact, merely subclinical hypothyroidism) who experienced hyperammonemic delirium during VPA treatment.
No takes yet. Share an insight, caveat, or question.
Hung et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: